News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
339,489 Results
Type
Article (20441)
Company Profile (131)
Press Release (318917)
Multimedia
Podcasts (75)
Webinars (11)
Section
Business (106402)
Career Advice (889)
Deals (18755)
Drug Delivery (97)
Drug Development (51919)
Employer Resources (80)
FDA (7792)
Job Trends (7823)
News (188194)
Policy (17474)
Tag
Academia (780)
Accelerated approval (3)
Adcomms (17)
Allergies (46)
Alliances (28158)
ALS (60)
Alzheimer's disease (665)
Antibody-drug conjugate (ADC) (103)
Approvals (7800)
Artificial intelligence (152)
Autoimmune disease (17)
Automation (6)
Bankruptcy (181)
Best Places to Work (5616)
BIOSECURE Act (13)
Biosimilars (99)
Biotechnology (60)
Bladder cancer (44)
Brain cancer (20)
Breast cancer (122)
Cancer (1199)
Cardiovascular disease (118)
Career advice (723)
Career pathing (21)
CAR-T (57)
Cell therapy (165)
Cervical cancer (6)
Clinical research (43623)
Collaboration (504)
Compensation (189)
Complete response letters (23)
COVID-19 (1133)
CRISPR (26)
C-suite (168)
Cystic fibrosis (60)
Data (1280)
Decentralized trials (2)
Denatured (19)
Depression (27)
Diabetes (149)
Diagnostics (1828)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (22)
Drug discovery (83)
Drug pricing (116)
Drug shortages (30)
Duchenne muscular dystrophy (63)
Earnings (39758)
Editorial (34)
Employer branding (10)
Employer resources (74)
Events (50148)
Executive appointments (477)
FDA (8481)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (344)
Gene editing (53)
Generative AI (18)
Gene therapy (157)
GLP-1 (610)
Government (1883)
Grass and pollen (3)
Guidances (76)
Healthcare (6129)
Huntington's disease (14)
IgA nephropathy (21)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1215)
Inflammatory bowel disease (93)
Inflation Reduction Act (8)
Influenza (25)
Intellectual property (59)
Interviews (117)
IPO (7530)
IRA (45)
Job creations (2439)
Job search strategy (654)
Kidney cancer (7)
Labor market (29)
Layoffs (290)
Leadership (16)
Legal (4130)
Liver cancer (34)
Lung cancer (178)
Lymphoma (97)
Machine learning (5)
Management (30)
Manufacturing (233)
MASH (54)
Medical device (2042)
Medtech (2045)
Mergers & acquisitions (11509)
Metabolic disorders (525)
Multiple sclerosis (56)
NASH (20)
Neurodegenerative disease (56)
Neuropsychiatric disorders (23)
Neuroscience (1010)
NextGen: Class of 2025 (2407)
Non-profit (921)
Now hiring (23)
Obesity (329)
Opinion (191)
Ovarian cancer (35)
Pain (76)
Pancreatic cancer (43)
Parkinson's disease (87)
Partnered (11)
Patents (159)
Patient recruitment (52)
Peanut (16)
People (33801)
Pharmaceutical (74)
Pharmacy benefit managers (22)
Phase I (13776)
Phase II (18531)
Phase III (14679)
Pipeline (872)
Policy (133)
Postmarket research (1621)
Preclinical (4951)
Press Release (29)
Prostate cancer (66)
Psychedelics (16)
Radiopharmaceuticals (161)
Rare diseases (257)
Real estate (3183)
Recruiting (29)
Regulatory (12707)
Reports (23)
Research institute (860)
Resumes & cover letters (139)
Rett syndrome (1)
RNA editing (2)
RSV (25)
Schizophrenia (63)
Series A (60)
Series B (38)
Service/supplier (7)
Sickle cell disease (37)
Special edition (16)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2040)
State (2)
Stomach cancer (9)
Supply chain (56)
Tariffs (51)
The Weekly (54)
Vaccines (296)
Venture capitalists (30)
Weight loss (247)
Women's health (14)
Worklife (8)
Date
Last 7 days (498)
Last 30 days (1523)
Last 365 days (16871)
2025 (6175)
2024 (18148)
2023 (20292)
2022 (26575)
2021 (27323)
2020 (25419)
2019 (20351)
2018 (15769)
2017 (17438)
2016 (16361)
2015 (19010)
2014 (14903)
2013 (12610)
2012 (13533)
2011 (13848)
2010 (12769)
Location
Africa (411)
Alabama (26)
Alaska (1)
Arizona (68)
Arkansas (8)
Asia (25120)
Australia (3297)
California (2834)
Canada (1209)
China (353)
Colorado (107)
Connecticut (107)
Delaware (81)
Europe (52111)
Florida (513)
Georgia (60)
Idaho (19)
Illinois (276)
India (20)
Indiana (178)
Iowa (3)
Japan (133)
Kansas (65)
Kentucky (18)
Louisiana (3)
Maine (5)
Maryland (393)
Massachusetts (2357)
Michigan (48)
Minnesota (144)
Mississippi (1)
Missouri (29)
Montana (10)
Nebraska (11)
Nevada (20)
New Hampshire (8)
New Jersey (1127)
New Mexico (21)
New York (843)
North Carolina (530)
North Dakota (2)
Northern California (1203)
Ohio (85)
Oklahoma (5)
Oregon (21)
Pennsylvania (679)
Puerto Rico (12)
Rhode Island (20)
South America (614)
South Carolina (4)
Southern California (1163)
Tennessee (40)
Texas (367)
United States (11244)
Utah (62)
Virginia (97)
Washington D.C. (47)
Washington State (265)
Wisconsin (25)
339,489 Results for "innate pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innate Pharma Announces €15M Investment by Sanofi
April 24, 2025
·
6 min read
Press Releases
Innate Pharma announces conference call and webcast for Q1 2025 business update
May 6, 2025
·
4 min read
Press Releases
Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum
April 3, 2025
·
4 min read
Press Releases
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025
April 16, 2025
·
5 min read
Press Releases
Innate Pharma Reports Full Year 2024 Financial Results and Business Update
March 27, 2025
·
19 min read
Press Releases
Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference
March 25, 2025
·
4 min read
Press Releases
Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results
March 20, 2025
·
4 min read
Press Releases
Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition
April 16, 2025
·
9 min read
Press Releases
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
February 27, 2025
·
4 min read
Press Releases
Innate Pharma Files Its 2024 Universal Registration Document (Document d’enregistrement universel) and 2024 Annual Report on Form 20-F
May 1, 2025
·
4 min read
1 of 33,949
Next
